ARS Pharmaceuticals Overview
ARS Pharmaceuticals Discounted Cash Flow
DCF Analysis for SPRY.
Get informed when a big investor buys or sells
+ FollowFair Value
$-5.96
Current Fair Value
$-5.96
↓ 161.1% Downside
Overvalued by 161.1% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison